In hamsters dopamine D2 receptors affect ventilation during and following intermittent hypoxia

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 148, Issue 3, 2007, Pages 674-680

  Schlenker, Evelyn H ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Body temperature; CO2 production; D2 receptor; Domperidone; Haloperidol; Hamster; Hypoxia; Ventilation

Indexed keywords

CARBON DIOXIDE; DOMPERIDONE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; DOPAMINE RECEPTOR BLOCKING AGENT;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BREATHING; CONTROLLED STUDY; EVALUATION; FACILITATION; FLOW MEASUREMENT; HAMSTER; HYPOXIA; LUNG VENTILATION; MALE; METABOLISM; NONHUMAN; REOXYGENATION; TIDAL VOLUME; ANIMAL; ANOXIA; CAROTID BODY; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; PATHOPHYSIOLOGY; SYRIAN HAMSTER; TIME;

CRICETINAE; MESOCRICETUS AURATUS;

ANIMALS; ANOXIA; BODY TEMPERATURE; CARBON DIOXIDE; CAROTID BODY; CRICETINAE; DISEASE MODELS, ANIMAL; DOMPERIDONE; DOPAMINE ANTAGONISTS; HALOPERIDOL; MALE; MESOCRICETUS; PULMONARY VENTILATION; RECEPTORS, DOPAMINE D2; TIDAL VOLUME; TIME FACTORS;

EID: 34748886158     PISSN: 10956433     EISSN: 15314332     Source Type: Journal    
DOI: 10.1016/j.cbpa.2007.08.020     Document Type: Article

References (35)

1. Bach K.B., and Mitchell G.S. Hypercapnia-induced long-term depression of respiratory activity requires alpha 2-adrenergic receptors. J. Appl. Physiol. 84 (1998) 2099-2105
2. Bairam A., Frenette J., Dauphin C., Carroll J.L., and Khandjian E.W. Expression of dopamine D1-receptor mRNA in the carotid body of adult rabbits, cats and rats. Neurosci. Res. 31 (1998) 147-154
3. Baker-Herman T.L., Fuller D.D., Bavis R.W., Zabka A.G., Golder F.J., Doperalski N.J., Johnson R.A., Watters J.J., and Mitchell G.S. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat. Neurosci. 7 (2004) 48-55
4. Barone J. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann. Pharmacother. 33 (1999) 429-440
5. Barros R.C.H., Branco L.G.S., and Carnio E.C. Evidence for thermoregulation by dopamine D1 and D2 receptors in the anteroventral preoptic region during normoxia and hypoxia. Brain Res. 1030 (2004) 165-171
6. Blessing W.W., and Ootsuka Y. Activation of dopamine D2 receptors in the CNS inhibits sympathetic cutaneous vasomotor alerting responses (SCVARs), contributing to clozapine's SCVAR-inhibiting action. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 (2007) 328-336
7. Carroll J.L., Boyle K.M., Wasicko M.J., and Sterni L.M. Dopamine D2 receptor modulation of carotid body type 1 cell intracellular calcium in developing rats. Am. J. Physiol., Lung Cell. Mol. Physiol. 288 (2005) L910-L916
8. Chipkin R.E. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats. Pharmacol. Biochem. Behav. 30 (1988) 683-686
9. Fick L.G., Fuller A., and Mitchel D. Thermoregulatory, motor, behavioural and nociceptive resposnes of rats to 3 long-acting neuroleptics. Can. J. Physiol. Pharm. 83 (2005) 517-527
10. Frappell P.B., and Mortola J.P. Hamsters vs. rats: metabolic and ventilatory response to development in chronic hypoxia. J. Appl. Physiol. 77 (1994) 2748-2752
11. Huey K.A., and Powell F.L. Time-dependent changes in dopamine D2-receptor mRNA in the arterial chemoreflex pathway with chronic hypoxia. Mol. Brain Res. 75 (2000) 264-270
12. Huey K.A., Brown I.P., Jordan M.C., and Powell F.L. Changes in dopamine D2-receptor modulation of the hypoxic ventilatory response with chronic hypoxia. Respir. Physiol. 123 (2000) 177-187
13. Huey K.A., Szewczak J.M., and Powell F.L. Dopaminergic mechanisms of neural plasticity in respiratory control: transgenic approaches. Respir. Physiol. Neurobiol. 135 (2003) 133-144
14. Kline D.D., Overholt J.L., and Prabhakar N.R. Mutant mice deficient in NOS-1 exhibit attenuated long-term facilitation and short-term potentiation in breathing. J. Physiol. 539 (2002) 309-315
15. Kline D.D., Takacs K.N., Ficker E., and Kunze D.L. Dopamine modulates synaptic transmission in the nucleus of the solitary tract. J. Neurophysiol. 88 (2002) 2736-2744
16. McGuire M., Zhang Y., White D.P., and Ling L. Effect of hypoxic episode number and severity on ventilatory long-term facilitation in awake rats. J. Appl. Physiol. 93 (2002) 2155-2161
17. McGuire M., Zhang Y., White D.P., and Ling L. Serotonin receptor subtypes required for ventilatory long-term facilitation and its enhancement after chronic intermittent hypoxia in awake rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 286 (2004) R334-R341
18. McGuire M., Zhang Y., White D.P., and Ling L. Phrenic long-term facilitation requires NMDA receptors in the phrenic motonucleus in rats. J. Physiol. (Lond) 567 (2005) 599-611
19. Millhorn D.E., Eldridge F.L., and Waldrop T.G. Pharmacologic study of respiratory afterdischarge. J. Appl. Physiol. 50 (1981) 239-244
20. Mitchell G.S., Baker T.L., Nanda S.A., Fuller D.D., Zabka A.G., Hodgeman B.A., Bavis R.W., Mack K.J., and Olson Jr. E.B. Invited review: intermittent hypoxia and respiratory plasticity. J. Appl. Physiol. 90 (2001) 2466-2475
21. Nakano H., Lee S.-D., and Farkas G.A. Dopaminergic modulation of ventilation in obese Zucker rats. J. Appl. Physiol. 92 (2002) 25-32
22. Nunes J., Sharif N.A., Michel A.D., and Whiting R.L. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem. Res. 16 (1991) 1167-1174
23. Olson Jr. E.B., Bohne C.J., Dwinell M.R., Podolsky A., Vidruk E.H., Fuller D.D., Powell F.L., and Mitchell G.S. Ventilatory long-term facilitation in unanesthetized rats. J. Appl. Physiol. 91 (2001) 709-716
24. Orset C., Parrot S., Sauvinet V., Cottet-Emard J.-M., Berod A., Pequignot J.-M., and Denoroy L. Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis. Neurochem. Int. 46 (2005) 623
25. Peng Y.-J., Yuan G., Ramakrishnan D., Sharma S.D., Bosch-Marce M., Kumar G.K., Semenza G.L., and Prabhakar N.R. Heterozygous HIF-1{alpha} deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J. Physiol. 577 (2006) 705-716
26. Richter A., and Löscher W. MK-801 potentiates antidystonic effects of clozapine but not of haloperidol in mutant dystonic hamsters. Brain Res. 769 (1997) 296-302
27. Schlenker E.H. An evaluation of ventilation in dystrophic Syrian hamsters. J. Appl. Physiol. 56 (1984) 914-921
28. Schlenker E.H. Serotoninergic and dopaminergic receptor antagonists eliminate ventilatory LTF in hamsters. 2006 Neuroscience Meeting Planner (2006), Society for Neuroscience, Atlanta, GA 154
29. Seeman P. Atypical antipsychotics: mechanism of action. Can. J. Physiol. Pharm. 47 (2002) 27-38
30. Serebrovskaya T.V., K. I.N., Kolesnikova E.E., Mishunina T.M., Kuzminskaya L.A., Serebovsky A.N., and Swanson R.J. Human hypoxic ventilatory response with blood dopamine content under intermittent hypoxic training. Can. J. Physiol. Pharm. 77 (1999) 967-973
31. Serebrovskaya T.V., Kolesnikova E.E., Mishunina T.M., Swanson R.J., Beloshitsky P.V., Ilyin V.N., Krasuk A.N., Safronova O.S., and Kuzminskaya L.A. Geriatric men at altitude: hypoxic ventilatory sensitivity and blood dopamine changes. Respiration 67 (2000) 253-260
32. Singh Y.N., Schlenker E.H., Singh B.N., and Burbach J.A. Consequences of thyroxine treatment on diaphragm and EDL of normal and dystrophic hamsters. Can. J. Physiol. Pharm. 82 (2004) 345-352
33. Subramanian S., Dostal J., Erokwu B., Han F., Dick T.E., and Strohl K.P. Domperidone and ventilatory behavior: Sprague-Dawley versus Brown Norway rats. Respir. Physiol. Neurobiol. 155 (2007) 22-28
34. Vincent S.G., Waddell A.E., Caron M.G., Walker J.K.L., and Fisher J.T. A murine model of hyperdopaminergic state displays altered respiratory control. FASEB J. 21 (2007) 1463-1471
35. Wang H., Yuan G., Prabhakar N.R., Boswell M., and Katz D.M. Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling. J. Neurochem. 96 (2006) 694-705